Lars Bastholt - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Lars Bastholt

This paper was not found in any repository, but could be made available legally by the author.

2024 Eva Ellebaek

ORCID

ORCID

, Lars Bastholt

ORCID

, Henrik Schmidt, Charlotte Aaquist Haslund, Marco Donia

ORCID

, Inge Marie Svane

PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt

ORCID

, Nicole Basset Seguin, Veronique Bataille, Lieve Brochez, Veronique del Marmol, Reinhard Dummer, Ana-Marie Forsea

ORCID

, Caroline Gaudy-Marqueste, Catherine A. Harwood, Axel Hauschild, Christoph Höller and 17 other authors

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Hafsa Ismail, Jens Helby, Lisbet R. Hölmich

ORCID

, Annette H. Chakera

ORCID

, Lars Bastholt

ORCID

, Helle Klyver, Pia Sjøgren, Henrik Schmidt, Liv Schöllhammer, Julia S. Johansen, Børge G. Nordestgaard

ORCID

, Stig E. Bojesen

ORCID

Measured and genetically predicted plasma YKL-40 levels and melanoma mortality

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ketty Peris, Maria Concetta Fargnoli, Claus Garbe

ORCID

, Roland Kaufmann, Lars Bastholt

ORCID

, Nicole Basset Seguin, Veronique Bataille, Veronique del Marmol, Reinhard Dummer, Catherine A. Harwood, Axel Hauschild, Christoph Höller, Merete Haedersdal, Josep Malvehy, Mark R. Middleton

ORCID

and 9 other authors

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Upload

This paper was not found in any repository, but could be made available legally by the author.

Lars Bastholt

ORCID

, Inge Marie Svane, Jon Kroll Bjerregaard

ORCID

, Jørn Herrstedt, Asbjørn Hróbjartsson, Henrik Schmidt

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

Upload

Missing publications? Search for publications with a matching author name.